Page last updated: 2024-11-12

rosarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rosarin: isolated from Rhodiola rosea; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
RhodiolagenusA plant genus of the family CRASSULACEAE. Members contain rhodioloside. This roseroot is unrelated to the familiar rose (ROSA). Some species in this genus are called stonecrop which is also a common name for SEDUM.[MeSH]CrassulaceaeThe stonecrop plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that grow in warm, dry regions. The leaves are thick. The flower clusters are red, yellow, or white.[MeSH]

Cross-References

ID SourceID
PubMed CID10320370
CHEBI ID137499
SCHEMBL ID14705646
MeSH IDM0521788

Synonyms (24)

Synonym
AC-6067
84954-93-8
CHEBI:137499
rosarin
SCHEMBL14705646
beta-d-glucopyranoside, (2e)-3-phenyl-2-propen-1-yl 6-o-alpha-l-arabinofuranosyl-
unii-pqa54l0kfi
Q-100857
PQA54L0KFI ,
rosarin (glycoside)
rosarin, (-)-
rosarin (constituent of rhodiola rosea) [dsc]
.beta.-d-glucopyranoside, (2e)-3-phenyl-2-propen-1-yl 6-o-.alpha.-l-arabinofuranosyl-
AKOS025402184
rosarin, >=98% (hplc)
(2r,3r,4s,5s,6r)-2-(cinnamyloxy)-6-((((2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)methyl)tetrahydro-2h-pyran-3,4,5-triol
HY-N0506
mfcd04039808
Q15424778
(2r,3s,4s,5r,6r)-2-[[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(e)-3-phenylprop-2-enoxy]oxane-3,4,5-triol
CS-0009046
AS-79330
rosarin (constituent of rhodiola rosea)
DTXSID601045580
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
O-acyl carbohydrateA carbohydrate derivative in which the hydrogen atom of at least one alcoholic hydroxy group of a carbohydrate has been replaced by an acyl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.57 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index61.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]